![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Short-term intravenous proton pump inhibitors and histamine H2 antagonists do not negatively affect
sustained virologic response in hepatitis C cirrhotic patients treated with ledipasvir or velpatasvir
containing antiviral regimens: a case series
|
|
|
Reported by Jules Levin
20th International Workshop on Clinical Pharmacology of HIV, Hepatitis & Other Antiviral Drugs. May 14-16, 2019. Noordwijk, the Netherlands
![0523191](../images/052319/052319-5/0523191.gif)
![0523192](../images/052319/052319-5/0523192.gif)
![0523193](../images/052319/052319-5/0523193.gif)
![0523194](../images/052319/052319-5/0523194.gif)
![0523195](../images/052319/052319-5/0523195.gif)
![0523196](../images/052319/052319-5/0523196.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|